-+ 0.00%
-+ 0.00%
-+ 0.00%

HSBC Maintains Hold on Bristol-Myers Squibb, Raises Price Target to $60

Benzinga·03/17/2026 15:52:07
Listen to the news
HSBC analyst Rajesh Kumar maintains Bristol-Myers Squibb (NYSE:BMY) with a Hold and raises the price target from $53 to $60.